anticonvulsant

Essential Reads: Breastfeeding and Anti-Epileptic Drugs

While data are limited regarding AEDs and breastfeeding, it appears that none of the AEDs are excreted at high levels into the breast milk, nor have they been associated with high rates of adverse events in the nursing infant.

By |2025-06-26T09:07:30-04:00August 10th, 2022|Anti-Epileptic Drugs, Breastfeeding & Medications, Essential Reads, Prevalence & Risk Factors|Comments Off on Essential Reads: Breastfeeding and Anti-Epileptic Drugs

Reassuring News: Neurodevelopmental Outcomes in Two-Year Olds with Prenatal Exposure to Lamotrigine (Lamictal)

These findings are encouraging and suggest that the newer AEDs, specifically lamotrigine and levetiracetam, are not associated with worse neurodevelopmental outcomes.

By |2025-06-26T09:06:51-04:00February 9th, 2022|Pregnancy & Medications|Comments Off on Reassuring News: Neurodevelopmental Outcomes in Two-Year Olds with Prenatal Exposure to Lamotrigine (Lamictal)

Prenatal Exposure to Valproic Acid Linked to Increased Risk for Autism, ADHD

Prenatal exposure to valproate has been associated with an elevated risk (10%) for a broad range of congenital malformations including neural tube defects, as well as adverse neurodevelopmental sequelae, including lower IQ and developmental delays [...]

By |2025-06-26T09:07:37-04:00February 9th, 2021|Anti-Epileptic Drugs, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Prenatal Exposure to Valproic Acid Linked to Increased Risk for Autism, ADHD

Lithium and Anticonvulsant Mood Stabilizers: No Higher Risk for Adverse Pregnancy Outcomes

For women with bipolar disorder, choosing whether to maintain or discontinue treatment with a mood stabilizer during pregnancy is challenging.  This is a process which requires careful and thoughtful consideration, weighing the risk of adverse [...]

By |2025-06-26T09:07:40-04:00August 5th, 2019|Pregnancy & Medications|Comments Off on Lithium and Anticonvulsant Mood Stabilizers: No Higher Risk for Adverse Pregnancy Outcomes

Behavior Problems More Common In Children with Prenatal Exposure to Valproic Acid

While we have considerable information regarding the teratogenic risk associated with prenatal exposure to various antiepileptic (AED) drugs, we have less impact on exposure to AEDs on behavior outcomes in children.  Several studies have shown [...]

By |2025-06-26T09:07:41-04:00July 15th, 2019|Anti-Epileptic Drugs, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Behavior Problems More Common In Children with Prenatal Exposure to Valproic Acid

Anti-Epileptic Drugs in Reproductive Age Women: Valproic Acid and Topiramate Commonly Used

There have long been concerns regarding the safety of the anticonvulsant valproic acid (Depakote) during pregnancy.  Back in 2009, the American Academy of Neurology and American Epilepsy Society recommended against the use of valproic acid [...]

By |2025-06-26T09:07:43-04:00April 9th, 2019|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Anti-Epileptic Drugs in Reproductive Age Women: Valproic Acid and Topiramate Commonly Used

Valproic Acid: Highlighting Risk and Modifying Prescribing Patterns in Reproductive Age Women

For clinicians who have not yet discovered the incredibly thoughtful and clinically practical monthly articles from Chittaranjan Andrade in the Journal of Clinical Psychiatry, it’s time to take a look.  (Not only are these articles [...]

By |2019-04-05T08:04:27-04:00July 3rd, 2018|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Valproic Acid: Highlighting Risk and Modifying Prescribing Patterns in Reproductive Age Women
Go to Top